Ledger.Open graph →

SEC Form D · filed June 17, 2019

Prelude Therapeutics Inc

Offering

$60.0M

Sold

$30.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Wilmington, DE

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Paul Friedman · New York, NYDirector Krishna Vaddi · Chadds Ford, PAExec · Director David Mauro · Wilmington, DEExec Krishna Vaddi · Chadds Ford, PAExec · Director Paul Friedman · San Francisco, CADirector Kelvin Neu · San Francisco, CADirector David Bonita · Montreal, Quebec, CanadaDirector Kelvin Neu · Newark, DEDirector David Bonita · New York, NYDirector Peggy Scherle · Wilmington, DEExec David Mauro · Wilmington, DEExec Peggy Scherle · Wilmington, DEExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗